If you survived the coronobius, it doesn't mean we're immune.

The results would have to help to understand the immune response and thus make it easier for them to decide for a vaccine, and those who have recovered from COVID-19 have attended this study.

“The study would have to help us understand whether one of these patients is developing immunity after infection. The findings of the study are aimed at building a solid base of arguments and facts for the start of developing a <x1 vaccine, Rudolf Valenta has declared the Centre for Patophisiology, Infective and Immmunology at Vienna Medical University.

We need to calculate the fact that the virus is now similar to the flu and that it can come up to repeating the” infection, Valenta explained.

Researchers from the Patophysiology, Infecta, and Immunology Centre are also conducting a test that will enable us to investigate whether antibodies can prevent the link to the host cell, while research is also planned for cell immune response.

“analysis will be very complex and we will not be able to tell the respondents immediately if they are immune or not”, Valenta added.

The model for the discovery of antibodies in patients who interfere with the interaction of viruses and receptors shows which part of the virus should be involved in the vaccine.

“From allergies and immun therapy we've received answers that antibodies can be produced with vaccinated”, says f und Valenta.

In more than 100 research projects involving COVIID-19, Vienna University employees are working on solutions that would contribute to pandemic control: from simulations, data analysis, epidemiological studies, basic bio-medical research, genetics, medical technology to clinical studies and results.